{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T01:51:50Z","timestamp":1785030710281,"version":"3.55.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,8,1]],"date-time":"1995-08-01T00:00:00Z","timestamp":807235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1007\/bf03324331","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T09:18:57Z","timestamp":1372756737000},"page":"164-173","source":"Crossref","is-referenced-by-count":10,"title":["Prevention and treatment of osteoporosis"],"prefix":"10.1007","volume":"7","author":[{"given":"M. C.","family":"Chapuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"BF03324331_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","volume":"341","author":"SR Cummings","year":"1993","unstructured":"Cummings S.R., Black D.M., Nevitt M.C., Browner W., Cauley J., Ensrud K., Genant H.K., Palermo L., Scott J., Vogt T.M.: Bone density at various sites for prediction of hip fractures. Lancet 341: 72\u201375, 1993.","journal-title":"Lancet"},{"key":"BF03324331_CR2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jbmr.5650081010","volume":"8","author":"LJ Melton","year":"1993","unstructured":"Melton L.J., Atkinson E.J., O\u2019Fallon W.M., Wahner H.W., Riggs B.L.: Long-term fracture prediction by bone mineral assessed at different skeletal sites. J. Bone Miner. Res. 8: 1227\u20131233, 1993.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR3","volume-title":"Assessement of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843","author":"World Health Organization","year":"1994","unstructured":"World Health Organization: Assessement of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva, 1994."},{"key":"BF03324331_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/bmj.309.6956.691","volume":"309","author":"G Jones","year":"1994","unstructured":"Jones G., Nguyen T., Sambrook P., Kelly P.J., Eisman J.A.: Progressive loss of bone in femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study. Br. Med. J. 309: 691\u2013695, 1994.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI110882","volume":"71","author":"PD Delmas","year":"1983","unstructured":"Delmas P.D., Stenner D., Wahner H.W., Mann K.G., Riggs B.L.: Increase in serum bone carboxyglutamic acid protein with aging in women. J. Clin. Invest. 71: 1316\u20131321, 1983.","journal-title":"J. Clin. Invest."},{"key":"BF03324331_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF01880417","volume":"1","author":"PJ Kelly","year":"1990","unstructured":"Kelly P.J., Eisman J.A., Sambrook P.N.: Interaction of genetic and environmental influences on peak bone density. Osteoporosis Int. 1: 56\u201360, 1990.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR7","first-page":"272","volume":"6SI","author":"CW Slemenda","year":"1991","unstructured":"Slemenda C.W, Miller J.Z., Reister T.K., Johnston C.C.: Site specific responses to intense physical activity in children, adolescents and young adults. J. Bone Miner. Res. 6SI: 272, 1991.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR8","volume-title":"Osteoporosis 1990","author":"JY Reginster","year":"1990","unstructured":"Reginster J.Y., Deroisy R, Sarlet N, Franchimont P.: Relation between calcium intake during periods of life and bone mineral content at the menopause. In: Christiansen C., Overgaard K. (Eds.), Osteoporosis 1990. Osteopress Publ., Copenhagen, 1990."},{"key":"BF03324331_CR9","first-page":"137","volume":"6SI","author":"CW Slemenda","year":"1991","unstructured":"Slemenda C.W., Miller J.Z., Reister T.K., Hui S.L., Johnston C.C.: Calcium supplementation enhances bone mineral accretion in growing children. J. Bone Miner. Res. 6SI: 137, 1991.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.298.6678.924","volume":"298","author":"JC Stevenson","year":"1989","unstructured":"Stevenson J.C., Lees B., Devenport M., Cust M.P., Ganger K.F.: Determinants of bone density in normal women: risk factors for future osteoporosis. Br. Med. J. 298: 924\u2013928, 1989.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM198711053171901","volume":"317","author":"DP Kiel","year":"1987","unstructured":"Kiel D.P., Felson D.T., Anderson J.J.: Hip fracture and the use of estrogens in postmenopausal women. The Framingham study. N. Engt. J. Med. 317: 1169\u20131174, 1987.","journal-title":"N. Engt. J. Med."},{"key":"BF03324331_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-95-1-28","volume":"95","author":"A Paganini-Hill","year":"1981","unstructured":"Paganini-Hill A., Ross R.K., Gerkins V.R., Henderson B.E., Arthur M., Mack T.M.: Menopausal estrogen therapy and hip fractures. Ann. Intern Med. 95: 28\u201331, 1981.","journal-title":"Ann. Intern Med."},{"key":"BF03324331_CR13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199009273231305","volume":"323","author":"B Dawson-Hughes","year":"1990","unstructured":"Dawson-Hughes B., Dallal G.E., Krall E.A., Sadowski L., Sahyoun N., Tannenbaum S.: A controlled triai of the effect of calcium supplementation on bone density in postmenopausal women. N. Engl. J. Med. 323: 878\u2013883, 1990.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01880410","volume":"1","author":"C Christiansen","year":"1990","unstructured":"Christiansen C., Lindsay R.: Estrogens, bone loss and preservation. Osteoporosis Int. 1: 7\u201313, 1990.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0002-9378(82)90176-4","volume":"144","author":"MS Chrisensen","year":"1982","unstructured":"Chrisensen M.S., Hagen C., Christiansen C., Transbon I.: Dose-response evaluation of cyclic estrogen\/gestagen in postmenopausal women. Placebo-controlled trial of its gynecologic and metabolic actions. Am. J. Obstet. Gynecol. 144: 873\u2013879, 1982.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03324331_CR16","first-page":"759","volume":"63","author":"R Lindsay","year":"1983","unstructured":"Lindsay R., Hart C.M., Clarke D.M.: The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet. Gynecol. 63: 759\u2013763, 1983.","journal-title":"Obstet. Gynecol."},{"key":"BF03324331_CR17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.3388021","volume":"241","author":"EF Eriksen","year":"1988","unstructured":"Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Speisberg T.C., Riggs B.L.: Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84\u201386, 1988.","journal-title":"Science"},{"key":"BF03324331_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.3164526","volume":"241","author":"BS Komm","year":"1988","unstructured":"Komm B.S., Terpening C.M., Benz D.J., Graeme K.A., Gallegos A., Korc M., Green G.L., O\u2019Malley B.W., Haussler M.R.: Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241: 81\u201384, 1988.","journal-title":"Science"},{"key":"BF03324331_CR19","first-page":"23","volume-title":"Spine vertebral osteoporosis","author":"EF Eriksen","year":"1994","unstructured":"Eriksen E.F., Lang Dahz B., Kassem M.: The cellular basis of osteoporosis. In: Cooper C., Reeve J. (Eds.), Spine vertebral osteoporosis. Harley Beefus, Philadelphia, 1994, pp. 23\u201362."},{"key":"BF03324331_CR20","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.1991.03460140089033","volume":"265","author":"E Barrett-Connor","year":"1991","unstructured":"Barrett-Connor E., Bush T.L.: Estrogen and coronary heart disease in women. J. Am. Med. Assoc. 265: 1861\u20131867, 1991.","journal-title":"J. Am. Med. Assoc."},{"key":"BF03324331_CR21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0140-6736(91)92526-8","volume":"337","author":"JP Vanderbroucke","year":"1991","unstructured":"Vanderbroucke J.P.: Postmenopausal oestrogen and cardioprotection. Lancet 337: 833\u2013834, 1991.","journal-title":"Lancet"},{"key":"BF03324331_CR22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1471-0528.1986.tb08035.x","volume":"93","author":"J Jensen","year":"1986","unstructured":"Jensen J., Nilas L., Christiansen C.: Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy. Br. J. Obstet. Gynaecol. 93: 616\u2013618, 1986.","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"BF03324331_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01627072","volume":"2","author":"TL Bush","year":"1991","unstructured":"Bush T.L.: Extraskeletal effects of estrogen and the prevention of atherosclerosis. Osteoporosis Int. 2: 5\u201311, 1991.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-5122(90)90008-T","volume":"12","author":"PM Sarrel","year":"1990","unstructured":"Sarrel P.M.: Ovarian hormones and the circulation. Maturitas 12: 287\u2013298, 1990.","journal-title":"Maturitas"},{"key":"BF03324331_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.298.6667.147","volume":"298","author":"I Peerson","year":"1989","unstructured":"Peerson I., Adami H.O., Bergkvist L., Lindgren A., Petterson B.: Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br. Med. J. 298: 147\u2013151, 1989.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L., Adami H.O., Persson I., Hoover R., Schairer C.: The risk of breast cancer after estrogen-progeston replacement. N. Engl. J. Med. 321: 293\u2013297, 1989.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jcem-71-4-836","volume":"71","author":"C Christiansen","year":"1990","unstructured":"Christiansen C., Riis B.J.: 17 Estradiol and continuous norethister-one: a unique treatment for established osteoporosis in elderly women. J. Clin. Endocrinol. Metab. 71: 836\u2013841, 1990.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03324331_CR28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01623239","volume":"4","author":"C Hasling","year":"1994","unstructured":"Hasling C., Charles P., Jensen F.T., Mosekilde L.: A comparison of the effects of oestrogen\/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis. Osteoporosis Int. 4: 191\u2013203, 1994.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.79.2.366","volume":"79","author":"KM Prestwood","year":"1994","unstructured":"Prestwood K.M., Pilbeam C.C., Burleson J.A., Woodiel F.N., Delmas P.D., Deftos L.J., Raisz L.G.: The short-term effects of conjugated estrogen on bone turnover in older women. J. Clin. Endocrinol. Metab. 79: 366\u2013371, 1994.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03324331_CR30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9378(94)70129-6","volume":"170","author":"JD Woodruff","year":"1994","unstructured":"Woodruff J.D., Pickar J.H.: Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am. J. Obstet. Gynecol. 170: 1216\u20131223, 1994.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03324331_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1471-0528.1994.tb13010.x","volume":"101","author":"J Rymer","year":"1994","unstructured":"Rymer J., Fogelman I., Chapman M.G.: The incidence of vaginal bleeding with tibolone treatment. Br. J. Obstet. Gynaecol. 101: 53\u201356, 1994.","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"BF03324331_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM198701223160401","volume":"316","author":"B Riis","year":"1987","unstructured":"Riis B., Thomsen K., Christiansen C.: Does calcium supplementation prevent postmenopausal bone loss; a double-blind, controlled clinical study. N. Engl. J. Med. 316: 173\u2013177, 1987.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jcem-73-3-533","volume":"73","author":"PJ Elders","year":"1991","unstructured":"Elders P.J., Netelendos J.C., Lips P., Vanginkel F.C., Koe E., Leewenkamp O.R., Hackeng W.H.Z., Van Der Stelt P.F.: Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J. Clin. Endocrinol. Metab. 73: 533\u2013540, 1991.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03324331_CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bmj.298.6668.205","volume":"298","author":"JA Kanis","year":"1989","unstructured":"Kanis J.A., Passmore R.: Calcium supplementation of the diet. I and II. Br. Med. J. 298: 205\u2013208, 1989.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(88)90065-7","volume":"II","author":"TL Hoolbrook","year":"1988","unstructured":"Hoolbrook T.L. Barrett-Connor E., Wingard D.L.: Dietary calcium and risk of hip fracture: a 14-year prospective population study. Lancet II: 1046\u20131049, 1988.","journal-title":"Lancet"},{"key":"BF03324331_CR36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.305.6862.1124","volume":"305","author":"JA Kanis","year":"1992","unstructured":"Kanis J.A. Johnell O., Gullberg B., Allender E., Dilsen G., Gennari C.: Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br. Med. J. 305: 1124\u20131128, 1992.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.308.6936.1081","volume":"308","author":"MC Chapuy","year":"1994","unstructured":"Chapuy M.C., Arlot M.E., Delmas P.D., Meunier P.J.: Prevention of hip fractures through reduction of senile secondary hyperparathyroidism. Effect of a 3-year calcium and vitamin D3 supplementation. Br. Med. J. 308: 1081\u20131082, 1994.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR38","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., Delmas P.D., Meunier P.J.: Vitamin D and calcium to prevent hip fractures in elderly women. N. Engl. J. Med. 327: 1637\u20131642, 1992.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90682-2","volume":"93","author":"MJ Mc Kenna","year":"1992","unstructured":"Mc Kenna M.J.: Differences in vitamin D status between countries in young adults and in elderly. Am. J. Med. 93: 69\u201377, 1992.","journal-title":"Am. J. Med."},{"issue":"1","key":"BF03324331_CR40","first-page":"S330","volume":"7","author":"PJ Meunier","year":"1992","unstructured":"Meunier P.J., Gozzo I., Chaumet-Riffaud P., Delmas P.D., Guignard M., Chapuy M.C., Duboeuf F.: Dose-effect on bone density and parathyroid function of intranasal salmon calcitonin when administered without calcium in postmenopausal women. J. Bone Miner. Res. 7 (Suppl. 1): Abstract 950, S330, 1992.","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"BF03324331_CR41","first-page":"S196","volume":"7","author":"C Ribot","year":"1992","unstructured":"Ribot C., Tremolliere F., Pouilles J.M., Chaumet-Riffaud P.: Long-term effects of nasal calcitonin on vertebral and femoral bone mass in early menopause: results of a controlled prospective 3-year study. J. Bone Miner. Res. 7 (Suppl. 1): S196, 1992.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR42","first-page":"155S","volume":"61","author":"JY Reginster","year":"1994","unstructured":"Reginster J.Y., Deroisy R., Franchimont P.: Traitement de l\u2019ost\u00e9oporose: donn\u00e9es actuelles et perspectives. Reu. Rheum. 61: 155S\u2013164S, 1994.","journal-title":"Reu. Rheum."},{"key":"BF03324331_CR43","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(89)92927-9","volume":"II","author":"JY Reginster","year":"1989","unstructured":"Reginster J.Y., Lecart M.P., Deroisy R., Sarlet N., Denis D., Ethgen D., Collette J., Franchimont P.: Prevention of postmenopausal bone loss by tiludronate. Lancet II: 1469\u20131471, 1989.","journal-title":"Lancet"},{"key":"BF03324331_CR44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/8756-3282(92)90450-B","volume":"13","author":"JY Reginster","year":"1992","unstructured":"Reginster J.Y.: Oral tiludronate: pharmacological properties and potential usefulness in Paget\u2019s disease of bone and osteoporosis. Bone 13: 351\u2013354, 1992.","journal-title":"Bone"},{"key":"BF03324331_CR45","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/art.1780350819","volume":"35","author":"JY Reginster","year":"1992","unstructured":"Reginster J.Y., Colson F., Morlock G., Combe B., Ethgen D., Geusens P.: Evaluation of efficacy and safety of oral tiludronate in Paget\u2019s disease of bone: a double-blind, dose ranging, placebo-controlled study. Arthritis Rheum. 35: 967\u2013974, 1992.","journal-title":"Arthritis Rheum."},{"key":"BF03324331_CR46","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T., Thamsborg G., Steiniche T., Genant H.K., Sorensen O.H.: Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N. Engl. J. Med. 322: 1265\u20131271, 1990.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/191184a0","volume":"191","author":"C Rich","year":"1961","unstructured":"Rich C., Ensinck F.: Effect of sodium fluoride on calcium metabolism of human beings. Nature 191: 184\u2013185, 1961.","journal-title":"Nature"},{"key":"BF03324331_CR48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jbmr.5650080106","volume":"8","author":"P Chavassieux","year":"1993","unstructured":"Chavassieux P., Chenu C., Valentin-Opran C., Delmas P.D., Boivin G., Chapuy M.C., Meunier P.J.: In vitro exposure to sodium fluoride does not modify activity of proliferation of human osteoblastic cells in primary cultures. J. Bone Miner. Res. 8: 37\u201344, 1993.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR49","first-page":"150","volume":"49","author":"ROC Oreffo","year":"1991","unstructured":"Oreffo R.O.C., Wells N., Johnston D.: Sodium fluoride does not stimulate mammalian osteoblast-like cells. Calcif. Tissue Int. 49: 150, 1991.","journal-title":"Calcif. Tissue Int."},{"key":"BF03324331_CR50","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1002\/jbmr.5650051361","volume":"5","author":"CG Bellows","year":"1990","unstructured":"Bellows C.G., Heersche J.M., Aubin J.E.: The effects of fluoride on osteoblast progenitors in vitro. J. Bone Miner. Res. 5: S101\u2013S105, 1990.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0026-0495(89)90232-1","volume":"38","author":"WKH Lau","year":"1989","unstructured":"Lau W.K.H., Farley J.R., Freeman T.K., Baylink D.J.: A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblast acid phosphatase. Metabolism 38: 858\u2013868, 1989.","journal-title":"Metabolism"},{"key":"BF03324331_CR52","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1007\/BF00675627","volume":"52","author":"D Burgener","year":"1993","unstructured":"Burgener D., Bonjour J.P., Caverzasio J.: Mechanisms of fluoride action on osteogenic cells: first evidence for increased tyrosine kinase activity. Calcif. Tissue Int. 52: S57, 1993.","journal-title":"Calcif. Tissue Int."},{"key":"BF03324331_CR53","first-page":"360","volume-title":"Clinical Disorders of Bone and Mineral Metabolism","author":"PJ Meunier","year":"1983","unstructured":"Meunier P.J., Galus K., Briancon D., Edouard C., Charhon S.: Treatment of idiopathic osteoporosis with sodium fluoride. In: Frame B., Potts J.T. (Eds.), Clinical Disorders of Bone and Mineral Metabolism. Excerpta Medica, Amsterdam, 1983, pp. 360\u2013363."},{"key":"BF03324331_CR54","first-page":"824","volume-title":"Osteoporosis 1987","author":"PJ Meunier","year":"1987","unstructured":"Meunier P.J., Briancon D., Chavassieux P., Edouard C., Boivin G., Conrozier T., Marcelli C., Pastoureau P., Delmas P.D., Casez J.P.: Treatment with fluoride: bone histomorphometric findings. In: Christiansen C., Johansen J.S., Riis B.J. (Eds.), Osteoporosis 1987. Norhaven A\/S, Viborg, 1987, pp. 824\u2013828."},{"key":"BF03324331_CR55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/8756-3282(87)90011-1","volume":"8","author":"SA Duursma","year":"1987","unstructured":"Duursma S.A., Glerum J.H., Van Dijk A., Bosch R., Kehkhoff H., Van Putten J., Raymakers J.A.: Responders and non-responders after fluoride therapy in osteoporosis. Bone 8: 131\u2013136, 1987.","journal-title":"Bone"},{"key":"BF03324331_CR56","first-page":"859","volume-title":"Calcium Regulation and Bone Metabolism, Basic and Clinical Aspects","author":"C Marcelli","year":"1987","unstructured":"Marcelli C., Arlot M., Boivin G., Chapuy M.C., Meunier PJ.: Comparison between responders and non-responders osteoporotic women treated for 2 years with sodium fluoride-Ca-Vitamin D. A histomorphometric and biochemical survey. In: Cohn D.V., Martin T.J., Meunier P.J. (Eds.), Calcium Regulation and Bone Metabolism, Basic and Clinical Aspects. Excerpta Medica, Amsterdam, 1987, p. 859."},{"issue":"1","key":"BF03324331_CR57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jbmr.5650051322","volume":"5","author":"PD Delmas","year":"1990","unstructured":"Delmas P.D., Dupuis J., Duboeuf F., Chapuy M.C., Meunier P.J.: Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J. Bone Miner. Res. 5 (Suppl. 1): 143\u2013147, 1990.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR58","first-page":"1","volume":"2","author":"B Rouveix","year":"1988","unstructured":"Rouveix B., Faurisson F.: Physiologie et pharmacocin\u00e9tique du monofluorophosphate disodiquecarbonate de calcium. Lettre du Pharmacologue 2: 1\u20134, 1988.","journal-title":"Lettre du Pharmacologue"},{"key":"BF03324331_CR59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(88)92834-6","volume":"II","author":"N Mamelle","year":"1988","unstructured":"Mamelle N., Meunier P.J., Dusan R., Guillaume M., Martin J.L., Gaucher A.: Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet II: 361\u2013365, 1988.","journal-title":"Lancet"},{"key":"BF03324331_CR60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0140-6736(90)91764-2","volume":"336","author":"N Mamelle","year":"1990","unstructured":"Mamelle N., Meunier P.J., Netter P.: Fluoride and vertebral fractures. Lancet 336: 243, 1990.","journal-title":"Lancet"},{"key":"BF03324331_CR61","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","volume":"322","author":"BL Riggs","year":"1990","unstructured":"Riggs B.L., Hodgson S.F., O\u2019Fallon W.M., Chao E.I., Wanner H.W., Muhs J.M.: Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N. Engl. J. Med. 322: 802\u2013809, 1990.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01625446","volume":"1","author":"M Kleerekoper","year":"1991","unstructured":"Kleerekoper M., Peterson E.L., Nelson D.A., Phillips E., Schork M.A., Tilley B.C., Parfitt A.M.: A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporosis Int. 1: 155\u2013161, 1991.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jbmr.5650090216","volume":"9","author":"BL Riggs","year":"1994","unstructured":"Riggs B.L., O\u2019Fallon W.M., Une A., Hodgson S.F., Wahner H.W., Muhs J.M.: Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. J. Bone Miner. Res. 9: 265\u2013275, 1994.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01624143","volume":"2","author":"JR Farley","year":"1992","unstructured":"Farley J.R., Wergedahl J.E., Farley J.R., Javier G.N., Schulz E.E., Talbot J.R.: Spinal fractures during fluoride therapy for osteoporosis: relationship to spinal density. Osteoporosis Int. 2: 213\u2013218, 1992.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR65","first-page":"527","volume-title":"Current Research in Gynecology and Obstetrics","author":"JD Ringe","year":"1991","unstructured":"Ringe J.D.: Monofluorophosphate prevents fractures in postmenopausal osteoporosis. In: Genazzani N. (Ed.), Current Research in Gynecology and Obstetrics. Casterton Hall, Parthenon, 1991, pp. 527\u2013531."},{"key":"BF03324331_CR66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01623306","volume":"2","author":"JD Ringe","year":"1995","unstructured":"Ringe J.D., Meunier P.J.: What is the future for fluoride in the treatment of osteoporosis. Osteoporosis Int. 2: 71\u201374, 1995.","journal-title":"Osteoporosis Int."},{"key":"BF03324331_CR67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","volume":"94","author":"Consensus Development Conference","year":"1993","unstructured":"Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am. J. Med. 94: 646\u2013650, 1993.","journal-title":"Am. J. Med."},{"issue":"1","key":"BF03324331_CR68","first-page":"146","volume":"5","author":"PD Delmas","year":"1990","unstructured":"Delmas P.D., Dupuis J., Duboeuf F., Chapuy M.C., Meunier P.J.: Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J. Bone Miner. Res. 5 (Suppl. 1): 146\u2013147, 1990.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR69","first-page":"690","volume":"14","author":"DW Dempster","year":"1993","unstructured":"Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R.: Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14: 690\u2013709, 1993.","journal-title":"Endocr. Rev."},{"key":"BF03324331_CR70","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1210\/en.134.5.2126","volume":"134","author":"L Mosekilde","year":"1994","unstructured":"Mosekilde L., Danielsen C.C., Gasser J.: The effect on vertebral bone mass and strength of long-term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone (1\u201338) and combination therapy, assessed in aged ovariectomized rats. Endoc. 134: 2126\u20132134, 1994.","journal-title":"Endoc."},{"key":"BF03324331_CR71","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/en.134.2.650","volume":"134","author":"CH Sogaard","year":"1994","unstructured":"Sogaard C.H., Wronski T.J., Mc Osker J.E., Mosekilde L.: The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates. Endocr. Res. 134: 650\u2013657, 1994.","journal-title":"Endocr. Res."},{"key":"BF03324331_CR72","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/en.134.4.1897","volume":"134","author":"H Kaji","year":"1994","unstructured":"Kaji H., Sugimoto T., Kanatami M., Miyauchi A., Kimura T., Sakakibara S., Fukase M., Chihara K.: Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity. Endoc. 134: 1897\u20131904, 1994.","journal-title":"Endoc."},{"key":"BF03324331_CR73","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jc.79.3.691","volume":"79","author":"SE Inzucchi","year":"1994","unstructured":"Inzucchi S.E., Robbins R.J.: Effects of growth hormone on human bone biology. J. Clin. Endocrinol. Metab. 79: 691\u2013694, 1994.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03324331_CR74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/8756-3282(94)90819-2","volume":"15","author":"I Denis","year":"1994","unstructured":"Denis I., Zerath E., Pointillart A.: Effects of exogenous growth hormone on bone mineralization and remodeling and on plasma calcitriol in intact pigs. Bone 15: 419\u2013424, 1994.","journal-title":"Bone"},{"key":"BF03324331_CR75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2796.1993.tb00740.x","volume":"234","author":"C Wuster","year":"1993","unstructured":"Wuster C., Blum W.F., Schlemilch S., Ranke M.B., Ziegler R.: Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J. Intern. Med. 234: 249\u2013255, 1993.","journal-title":"J. Intern. Med."},{"key":"BF03324331_CR76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02556587","volume":"38","author":"G Mazzuoli","year":"1986","unstructured":"Mazzuoli G., Passen M., Gennari C., Minisola S., Antonelli R., Valtorta C., Palummeri E., Cervelin G.F., Gonnelli S., Francini G.: Effects of salmon calcitonin in postmenopausal osteoporosis; a controlled double blind study. Calcif. Tissue Int. 38: 3\u20138, 1986.","journal-title":"Calcif. Tissue Int."},{"key":"BF03324331_CR77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.1989.tb00443.x","volume":"30","author":"K Overgaard","year":"1989","unstructured":"Overgaard K., Riis B.J., Christiansen C., Podenphant J., Johansen J.: Nasal calcitonin for treatment of established osteoporosis. Clin. Endocrinol. (Oxf.) 30: 435\u2013442, 1989.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03324331_CR78","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1172\/JCI113725","volume":"82","author":"R Civitelli","year":"1988","unstructured":"Civitelli R., Gonelli S., Zacchei F., Rigazzi S., Vatimo A., Avioli L.V., Gennari C.: Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J. Clin. Invest. 82: 1268\u20131274, 1988.","journal-title":"J. Clin. Invest."},{"key":"BF03324331_CR79","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","volume":"305","author":"K Overgaard","year":"1992","unstructured":"Overgaard K., Hansen M.A., Jensen S.B., Christiansen C.: Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. Br. Med. J. 305: 556\u2013561, 1992.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00297179","volume":"55","author":"K Overgaard","year":"1994","unstructured":"Overgaard K.: Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study. Calcif. Tissue Int. 55: 82\u201386, 1994.","journal-title":"Calcif. Tissue Int."},{"key":"BF03324331_CR81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00310161","volume":"55","author":"N Munk Nielsen","year":"1994","unstructured":"Munk Nielsen N., Von Der Recke P., Hansen M.A., Overgaard K., Christiansen C.: Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers. Calcif. Tissue Int. 55: 8\u201311, 1994.","journal-title":"Calcif. Tissue Int."},{"key":"BF03324331_CR82","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.309.6956.711","volume":"309","author":"JE Compston","year":"1994","unstructured":"Compston J.E.: The therapeutic use of bisphosphonate. Br. Med. J. 309: 711\u2013715, 1994.","journal-title":"Br. Med. J."},{"key":"BF03324331_CR83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cpt1976205593","volume":"20","author":"RP Heaney","year":"1976","unstructured":"Heaney R.P., Saville P.D.: Etidronate disodium in postmenopausal osteoporosis. Clin. Pharma Ther. 20: 593\u2013604, 1976.","journal-title":"Clin. Pharma Ther."},{"key":"BF03324331_CR84","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","volume":"95","author":"ST Harris","year":"1992","unstructured":"Harris S.T., Watts N.B., Jackson R.D., Genant H.K., Wasnich R.D., Ros P., Miller P.D., Licata A.A., Chesnut C.H.: Fouryear study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am. J. Med. 95: 557\u2013567, 1992.","journal-title":"Am. J. Med."},{"issue":"1","key":"BF03324331_CR85","first-page":"S136","volume":"9","author":"DW Axelrod","year":"1994","unstructured":"Axelrod D.W., Teitelbaum S.L.: Results of long-term cyclical etidronate therapy: bone histomorphometry and clinical correlates. J. Bone Miner. Res. 9 (Suppl. 1): S136, 1994.","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"BF03324331_CR86","first-page":"S396","volume":"9","author":"SA Khan","year":"1994","unstructured":"Khan S.A., McCloskey E.V., Orgee J., Coombes G., Yates AJ.P., Kanis J.A.: Comparative effects of alendronate and etidronate in postmenopausal osteoporosis. J. Bone Miner. Res. 9 (Suppl. 1): S396, 1994.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","volume":"326","author":"MW Tilyard","year":"1992","unstructured":"Tilyard M.W., Spears G.F.S., Thomson J., Dovey S.: Treatment of postmenopausal osteoporosis with calcitriol or calcium. N. Engl. J. Med. 326: 357\u2013362, 1992.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-9343(88)90259-8","volume":"84","author":"JF Aloia","year":"1988","unstructured":"Aloia J.F., Vaswani A., Yeh J.K., Ellis K., Yasumura S., Cohn S.H.: Calcitriol in the treatment of postmenopausal osteoporosis. Am. J. Med. 84: 401\u2013408, 1988.","journal-title":"Am. J. Med."},{"key":"BF03324331_CR89","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-113-9-649","volume":"113","author":"JC Gallagher","year":"1990","unstructured":"Gallagher J.C., Goldgar D.: Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann. Intern. Med. 113: 649\u2013655, 1990.","journal-title":"Ann. Intern. Med."},{"key":"BF03324331_CR90","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-110-4-267","volume":"110","author":"SM Ott","year":"1989","unstructured":"Ott S.M., Chesnut C.H. III.: Calcitriol is not effective in postmenopausal osteoporosis. Ann. Intern. Med. 110: 267\u2013274, 1989.","journal-title":"Ann. Intern. Med."},{"key":"BF03324331_CR91","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM199202063260609","volume":"326","author":"CH Chesnut III.","year":"1992","unstructured":"Chesnut C.H. III.: Osteoporosis and its treatment. N. Engl. J. Med. 326: 406\u2013407, 1992.","journal-title":"N. Engl. J. Med."},{"key":"BF03324331_CR92","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jbmr.5650071107","volume":"7","author":"PE Keeting","year":"1992","unstructured":"Keeting P.E., Oursler M.J., Wiegand K.E., Bonde S.K., Spelsberg T.C., Riggs B.L.: Zeolite A increases proliferation, differentiation, and transforming growth factor \u03b2 production in normal adult human osteoblast-like cells in vitro. J. Bone Miner. Res. 7: 1281\u20131289, 1992.","journal-title":"J. Bone Miner. Res."},{"key":"BF03324331_CR93","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF01321834","volume":"53","author":"M Hott","year":"1993","unstructured":"Hott M., De Pollak C., Modrovski D., Marie P.J.: Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif. Tissue Int. 53: 174\u2013179, 1993.","journal-title":"Calcif. Tissue Int."}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03324331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03324331\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03324331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:20:45Z","timestamp":1715617245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03324331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["BF03324331"],"URL":"https:\/\/doi.org\/10.1007\/bf03324331","relation":{},"ISSN":["1594-0667","1720-8319"],"issn-type":[{"value":"1594-0667","type":"print"},{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}